cas 63089-56-5|| where to buy 1,2,3,5,6,7-Hexahydro-s-indacen-4-amine

Nom du produit:1,2,3,5,6,7-Hexahydro-s-indacen-4-amine

IUPAC Name:1,2,3,5,6,7-hexahydro-s-indacen-4-amine

Unité d'emballage	Stock disponible	Prix($)	Quantité
CM219878-25g	in stock	ǜǜȺ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 63089-56-5 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:63089-56-5; Formule moléculaire:C12H15N; Point de fusion:-; Code SMILES:NC1=C2CCCC2=CC3=C1CCC3; Densité:

: Numéro de catalogue:CM219878; Poids moléculaire:173.26; Point d'ébullition:; N° Mdl:; Stockage:Keep in dark place, inert atmosphere, store at room temperature.

: Indenes; Indenes are useful building blocks found in a variety of biologically relevant products.

: Benzenes; Benzene is an important organic compound with the chemical formula C6H6, and its molecule consists of a ring of 6 carbon atoms, each with 1 hydrogen atom. Benzene is a sweet, flammable, colorless and transparent liquid with carcinogenic toxicity at room temperature, and has a strong aromatic odor. It is insoluble in water, easily soluble in organic solvents, and can also be used as an organic solvent itself. The ring system of benzene is called benzene ring, and the structure after removing one hydrogen atom from the benzene ring is called phenyl. Benzene is one of the most important basic organic chemical raw materials. Many important chemical intermediates can be derived from benzene through substitution reaction, addition reaction and benzene ring cleavage reaction.

: NT-0796; NodThera’s NLRP3 inhibitor NT-0796 reverses neuroinflammation in Parkinson’s Disease phase Ib/IIa trial. The positive data from its Phase Ib/IIa study indicates that NT-0796 reduces key neuroinflammatory and inflammatory biomarkers in Parkinson’s disease patients to the levels found in healthy elderly controls over 28 days.
The NLRP3 inflammasome is a main mediator of inflammation in many pathologies. NT-0796 selectively inhibits NLRP3, lowering levels of both pro-inflammatory cytokines IL-1β and IL-18. This action delivers therapeutic effects directly to immune cell types responsible for inflammatory diseases, including peripheral and neuroinflammatory diseases.